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Background 
Chagas disease, also known as American 
Trypanosomiasis, is endemic in the Americas, 
especially Central and South America. Chagas disease 
is a zoonotic disease caused by the parasite 
Trypanosoma cruzi. Most of the infections take place 
in children by vector or congenital transmission, with 
other modes of infection such as blood transfusion, 
organ transplants, and oral route being less frequent. In 
areas under vectorial control, congenital transmission 
is the most common way of accruing the disease 1. 
The important population migratory movements of 
the last decades have significantly impacted public 
health. People migrate not just with their culture, 
beliefs and hopes, but also with their health problems. 
Many diseases, such as Chagas disease, can thus be 
transferred to new regions and progress silently due to 
lack of knowledge of the local health system, and 
eventually produce autochthonous cases. 
Vector transmission of the disease takes place 
mostly in rural areas. In Argentina, this is limited to 
the north of the country, in the provinces of Santiago 
del Estero, Chaco, Formosa, Corrientes, Santa Fe, 
Tucumán, and Salta, with isolated cases also reported 
in the rural areas of Cordoba and Mendoza. In areas 
where vectors are better controlled, congenital 
infection has become the main route of transmission. 
The City of Buenos Aires is not currently an endemic 
area for the vector. 
In 1991, the World Health Organization (WHO) 
promoted a plan to control the vector and to screen 
blood donors. This project, called the “South Cone 
Initiative”, led to a marked decrease in vector and 
blood-borne transmission. 
The Pan-American Health Organization (PAHO) 
estimates that there are currently 1,600,000 infected 
people in Argentina, and approximately 1,000 new 
congenital infections every year i. Prevalence of 
Chagas disease in pregnant women in Latin America 
ranges from 5% to 40% depending on geographical 
area, and the rate of congenital transmission is 
estimated to be 4% to 10%. An infected mother can 
have several infected children, as vertical transmission 
of the infection can take place in either the acute or 
chronic stage. 
Recently, migratory flows have changed the 
epidemiological landscape of Chagas disease from 
predominantly rural areas to a prevalent urban setting. 
It is estimated that most infected patients currently live 
in large cities. Also, migration has led to Chagas 
disease cases being described in non-endemic regions 
such as European countries (e.g., Spain, France, 
Switzerland), United States of America, Australia and 
even Japan, among others 2. As previously 
mentioned, an important consequence of these 
movements of infected people outside the geographic 
area of the vector is that, currently, most of the new 
cases are due to congenital infection 2,3. 
According to the 2010 Argentine National Census, 
over 53% of the population of Argentina lives in 
urbanized areas of the Province of Buenos Aires and 
the City of Buenos Aires, a non-endemic region for the 
vector. The City of Buenos Aires in particular has 
received a large flow of migrants from the north of the 
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country and from neighboring countries with a high 
prevalence of infection such as Bolivia, Paraguay and 
Peru 2. Argentina harbors 550,713 Paraguayan 
citizens, 345,272 Bolivians, and 157,514 Peruvians. 
From this migrant population, 85.9% of Paraguayans, 
65% of Bolivians, and 82.4% of Peruvians live in 
urbanized areas of the Province of Buenos Aires and 
the City of Buenos Aires 5. 
The relatively high birth rates of these populations 
may explain the increase in congenital cases observed 
in the last decade 2. It has been estimated that 
approximately 1,000 to 1,300 infected children are 
born every year in Argentina 1,2]. According to the 
Argentine National Chagas Program, of the 22,798 
births in 2010 reported in the City of Buenos Aires, 
3.4% were from mothers infected with chronic Chagas 
disease. Forty-one percent of these mothers were 
originally from the north of Argentina (mostly from 
the endemic provinces of Santiago del Estero and 
Chaco), 29% from Bolivia, 18% from Paraguay, and 
9% from Peru.However, the actual prevalence of 
Chagas disease in the City of Buenos Aires has not 
been thoroughly studied 2. 
 
The study 
Between 2005 and 2009 we performed a 
multicenter prevalence study of Chagas disease in 
primary care centers of the City of Buenos Aires. 
These centers (Neighborhoods 1, 7 and 9) are staffed 
by multidisciplinary health teams that cater to the 
health needs of low-income areas of the city where 
many newcomers live (Figure). 
The target population of these centers in these 
neighborhoods includes over 200,000 people. A total 
of 1,786 subjects were included in the study. 
Demographic data including age, origin, place of birth, 
travel history and family structure were collected for 
all included patients. The study was approved by the 
Ethics and Research Review Boards, Buenos Aires 
Children´s Hospital “R Gutierrez”, Argentina. Written 
informed consent was obtained from the patients or the 
patients' legal representatives, as appropriate. 
 
Results 
We observed a prevalence of 4.3% of Chagas 
disease infection in the population studied (n: 1786). 
Over half of the subjects in the study were female 
(68.6%); the median age was 19.2 years (range 8 
months to 40 years), with 73% younger than 20 years 
old. Approximately 60% were Argentine, 17% 
Bolivian, 12% Peruvian, and 10% Paraguayan. The 
main risk factors for infection were the following: 
having a family member with Chagas disease, being 
familiar with the vector (i.e., stating to know how to 
identify the vector), being born in Bolivia, and, in 
those from Argentina, being born in the province of 
Figure. Migrant population growth in the areas examined in our study between 2001 and 2010  
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Santiago del Estero. 
We also observed higher infection prevalence in 
school-age children than previously reported 6 in 
other areas of the city, likely due to the characteristics 
of the studied population, with a low percentage of 
immigrants from endemic areas. 
Our study allowed for the identification and 
treatment of seven children with congenital infection. 
Treatment with benznidazole was well tolerated, and 
led to therapeutic response in all children. 
The Parasitology and Chagas Service at “Ricardo 
Gutierrez” Children’s Hospital in Buenos Aires, 
Argentina, is a referral center for Chagas disease with 
over 1,500 annual consultations, and approximately 
650 children are currently being treated or under 
follow-up care for the disease. The mothers of these 
children were born in Argentina (57%), Bolivia 
(36.5%), and Brazil (6.5%). Approximately 50% of 
the mothers born in Argentina (194/370) came from 
endemic regions in the country. Sixteen percent of 
Argentine mothers were originally from the City of 
Buenos Aires and had never visited endemic areas nor 
received transfusions, making congenital transmission 
the most likely route of infection, and their infected 
children the second generation of congenital infection. 
 
Conclusion 
The majority of new Chagas disease cases 
originate in the City of Buenos Aires by vertical 
transmission. Many infections are actually second-
generation congenital cases, meaning that their 
mothers were themselves congenital cases. These 
findings highlight the fact that active screening for 
Chagas disease in urban settings should be considered 
an important component of childhood screening 
programs, particularly taking into account the high rate 
of pediatric response to treatment 2,3. 
An undiagnosed individual with Chagas disease 
can eventually become a blood donor or, in the case of 
women, give birth to children with congenital 
infections, thus perpetuating the cycle of infection in 
non-endemic areas.  
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